These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 31006876

  • 1. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
    Chen K, Mu F, Xie J, Kelkar SS, Olivier C, Signorovitch J, Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
    [Abstract] [Full Text] [Related]

  • 2. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, Messing B, Loth S, Youssef NN, Heinze H, Berghöfer P.
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [Abstract] [Full Text] [Related]

  • 3. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
    Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C.
    Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
    [Abstract] [Full Text] [Related]

  • 4. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C.
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [Abstract] [Full Text] [Related]

  • 5. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR, Kunecki M, Boullata JI, Fujioka K, Joly F, Gabe S, Pape UF, Schneider SM, Virgili Casas MN, Ziegler TR, Li B, Youssef NN, Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
    [Abstract] [Full Text] [Related]

  • 6. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
    Joly F, Seguy D, Nuzzo A, Chambrier C, Beau P, Poullenot F, Thibault R, Armengol Debeir L, Layec S, Boehm V, Lallemand J, Quilliot D, Schneider SM.
    Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
    [Abstract] [Full Text] [Related]

  • 7. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
    Ukleja A, To C, Alvarez A, Lara LF.
    JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
    [Abstract] [Full Text] [Related]

  • 8. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B.
    Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
    [Abstract] [Full Text] [Related]

  • 9. Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
    Chen K, Joly F, Mu F, Kelkar SS, Olivier C, Xie J, Seidner DL.
    Clin Nutr ESPEN; 2021 Jun; 43():420-427. PubMed ID: 34024550
    [Abstract] [Full Text] [Related]

  • 10. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ.
    Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
    [Abstract] [Full Text] [Related]

  • 11. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL, Fujioka K, Boullata JI, Iyer K, Lee HM, Ziegler TR.
    Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
    [Abstract] [Full Text] [Related]

  • 12. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.
    Kocoshis SA, Merritt RJ, Hill S, Protheroe S, Carter BA, Horslen S, Hu S, Kaufman SS, Mercer DF, Pakarinen MP, Venick RS, Wales PW, Grimm AA.
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):621-631. PubMed ID: 31495952
    [Abstract] [Full Text] [Related]

  • 13. Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
    Seidner DL, Gabe SM, Lee HM, Olivier C, Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):697-702. PubMed ID: 31423614
    [Abstract] [Full Text] [Related]

  • 14. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
    Micic D, Robinson I, Kidd T, Terreri B, Raphael BP.
    Nutr Clin Pract; 2024 Jun; 39(3):634-640. PubMed ID: 38491966
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
    Germán-Díaz M, Alcolea A, Cabello V, Blasco-Alonso J, Rodríguez A, Galera R, García-Romero R, Romero C, González-Sacristán R, Redecillas-Ferreiro S, Moreno-Villares JM, Ramos-Boluda E.
    Eur J Pediatr; 2024 Aug; 183(8):3173-3182. PubMed ID: 38664251
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Teduglutide: A Review in Short Bowel Syndrome.
    Kim ES, Keam SJ.
    Drugs; 2017 Mar; 77(3):345-352. PubMed ID: 28194723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.